Virginia Tech Identifies Protein Targets to Reverse Lung Scarring

The briefing

Researchers identified two proteins whose blockade halted and even reversed lung scarring in pre-clinical models of idiopathic pulmonary fibrosis. The results point to a promising therapeutic strategy pending further validation and clinical trials.